-
1
-
-
0041333144
-
Thrombosis prophylaxis in patient populations with a central venous catheter: A systematic review
-
Klerk CP, Smorenburg SM, Buller HR. Thrombosis prophylaxis in patient populations with a central venous catheter: A systematic review. Arch Intern Med 2003; 163: 1913-1921.
-
(2003)
Arch Intern Med
, vol.163
, pp. 1913-1921
-
-
Klerk, C.P.1
Smorenburg, S.M.2
Buller, H.R.3
-
2
-
-
0141973788
-
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients
-
Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003; 21: 3665-3675.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3665-3675
-
-
Verso, M.1
Agnelli, G.2
-
3
-
-
40149085869
-
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
-
Boersma RS, Jie KS, Verbon A et al. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 2008; 19: 433-442.
-
(2008)
Ann Oncol
, vol.19
, pp. 433-442
-
-
Boersma, R.S.1
Jie, K.S.2
Verbon, A.3
-
4
-
-
39049146634
-
Management of venous port systems in oncology: A review of current evidence
-
Vescia S, Baumgärtner AK, Jacobs VR et al. Management of venous port systems in oncology: A review of current evidence. Ann Oncol 2008; 19: 9-15.
-
(2008)
Ann Oncol
, vol.19
, pp. 9-15
-
-
Vescia, S.1
Baumgärtner, A.K.2
Jacobs, V.R.3
-
5
-
-
1842556758
-
Thrombotic complications of central venous catheters in cancer patients
-
Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004; 9: 207-216.
-
(2004)
Oncologist
, vol.9
, pp. 207-216
-
-
Kuter, D.J.1
-
7
-
-
0035333884
-
-
Fervers B, Hardy J, Blanc-Vincent MP et al. SOR: Project methodology. Br J Cancer 2001; 84 (Suppl 2): 8-16.
-
Fervers B, Hardy J, Blanc-Vincent MP et al. SOR: Project methodology. Br J Cancer 2001; 84 (Suppl 2): 8-16.
-
-
-
-
8
-
-
3042741116
-
International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument
-
Burgers JS, Fervers B, Haugh M et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol 2004; 22: 2000-2007.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2000-2007
-
-
Burgers, J.S.1
Fervers, B.2
Haugh, M.3
-
9
-
-
16844368771
-
Predictors of high quality clinical practice guidelines: Examples in oncology
-
Fervers B, Burgers JS, Haugh MC et al. Predictors of high quality clinical practice guidelines: Examples in oncology. Int J Qual Health Care 2005; 17: 123-132.
-
(2005)
Int J Qual Health Care
, vol.17
, pp. 123-132
-
-
Fervers, B.1
Burgers, J.S.2
Haugh, M.C.3
-
10
-
-
69849109565
-
-
Standards, Options: Recommendations. http://www.sor-cancer.fr/ (31 July 2008, date last accessed).
-
Standards, Options: Recommendations. http://www.sor-cancer.fr/ (31 July 2008, date last accessed).
-
-
-
-
11
-
-
0037323867
-
Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project
-
AGREE Collaboration
-
AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care 2003; 12: 18-23.
-
(2003)
Qual Saf Health Care
, vol.12
, pp. 18-23
-
-
-
12
-
-
23044505564
-
Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
-
Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 692-694
-
-
Schulman, S.1
Kearon, C.2
-
13
-
-
34249988241
-
-
Cucherat M. Guide de lecture critique d'un essai the' rapeutique. Me' decine The' rapeutique 2006; 12: 354-358. http://www.spc.univ-lyon1.fr/ lecturecritique/grille%20de%20lecture/frame1.htm (31 July 2008, date last accessed).
-
Cucherat M. Guide de lecture critique d'un essai the' rapeutique. Me' decine The' rapeutique 2006; 12: 354-358. http://www.spc.univ-lyon1.fr/ lecturecritique/grille%20de%20lecture/frame1.htm (31 July 2008, date last accessed).
-
-
-
-
14
-
-
0025237877
-
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
-
Bern MM, Lokich JJ, Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-428.
-
(1990)
Ann Intern Med
, vol.112
, pp. 423-428
-
-
Bern, M.M.1
Lokich, J.J.2
Wallach, S.R.3
-
15
-
-
0036379760
-
Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis
-
Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 2002; 32: 84-88.
-
(2002)
Intern Med J
, vol.32
, pp. 84-88
-
-
Heaton, D.C.1
Han, D.Y.2
Inder, A.3
-
16
-
-
23044444287
-
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer
-
Couban S, Goodyear M, Burnell M et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4063-4069
-
-
Couban, S.1
Goodyear, M.2
Burnell, M.3
-
17
-
-
33646072894
-
WARP - a multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs)
-
Abstr LBA8004
-
Young AM, Begum J, Billingham LJ et al. WARP - a multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). J Clin Oncol 2005; 16s (Suppl): (Abstr LBA8004).
-
(2005)
J Clin Oncol
, vol.16 s
, Issue.SUPPL.
-
-
Young, A.M.1
Begum, J.2
Billingham, L.J.3
-
18
-
-
33748636265
-
Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - a randomized, controlled study
-
Ruud E, Holmstrom H, De Lange C et al. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - a randomized, controlled study. Acta Paediatr 2006; 95: 1053-1059.
-
(2006)
Acta Paediatr
, vol.95
, pp. 1053-1059
-
-
Ruud, E.1
Holmstrom, H.2
De Lange, C.3
-
19
-
-
36349003559
-
Thromboprophylaxis for catheterrelated thrombosis in patients with cancer: A systematic review of the randomized, controlled trials
-
Carrier M, Tay J, Fergusson D, Wells PS. Thromboprophylaxis for catheterrelated thrombosis in patients with cancer: A systematic review of the randomized, controlled trials. J Thromb Haemost 2007; 5: 2552-2554.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 2552-2554
-
-
Carrier, M.1
Tay, J.2
Fergusson, D.3
Wells, P.S.4
-
20
-
-
35548933238
-
The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: A meta-analysis
-
Rawson KM, Newburn-Cook CV. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: A meta-analysis. Oncol Nurs Forum 2007; 34: 1037-1043.
-
(2007)
Oncol Nurs Forum
, vol.34
, pp. 1037-1043
-
-
Rawson, K.M.1
Newburn-Cook, C.V.2
-
21
-
-
34548814140
-
Prevention of central venous catheter-associated thrombosis: A meta-analysis
-
Kirkpatrick A, Rathbun S, Whitsett T, Raskob G. Prevention of central venous catheter-associated thrombosis: A meta-analysis. Am J Med 2007; 120: 901-913.
-
(2007)
Am J Med
, vol.120
, pp. 901-913
-
-
Kirkpatrick, A.1
Rathbun, S.2
Whitsett, T.3
Raskob, G.4
-
22
-
-
37849016457
-
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
-
CD006468
-
Akl EA, Karmath G, Yosuico V et al. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database Syst Rev 2007; CD006468.
-
(2007)
Cochrane Database Syst Rev
-
-
Akl, E.A.1
Karmath, G.2
Yosuico, V.3
-
23
-
-
38349104201
-
Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis
-
Chaukiyal P, Nautiyal A, Radhakrishnan S et al. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost 2008; 99: 38-43.
-
(2008)
Thromb Haemost
, vol.99
, pp. 38-43
-
-
Chaukiyal, P.1
Nautiyal, A.2
Radhakrishnan, S.3
-
24
-
-
0037441969
-
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: Can it be safely associated with fluorouracil-based chemotherapy?
-
Masci G, Magagnoli M, Zucali PA et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: Can it be safely associated with fluorouracil-based chemotherapy? J Clin Oncol 2003; 21: 736-739.
-
(2003)
J Clin Oncol
, vol.21
, pp. 736-739
-
-
Masci, G.1
Magagnoli, M.2
Zucali, P.A.3
-
25
-
-
0038349649
-
Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen
-
Magagnoli M, Masci G, Carnaghi C et al. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen. Ann Oncol 2003; 14: 959-960.
-
(2003)
Ann Oncol
, vol.14
, pp. 959-960
-
-
Magagnoli, M.1
Masci, G.2
Carnaghi, C.3
-
26
-
-
29844454065
-
High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5- fluorouracil-based regimens
-
Magagnoli M, Masci G, Castagna L et al. High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5- fluorouracil-based regimens. Ann Oncol 2006; 17: 174-176.
-
(2006)
Ann Oncol
, vol.17
, pp. 174-176
-
-
Magagnoli, M.1
Masci, G.2
Castagna, L.3
-
27
-
-
4544290127
-
Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease
-
Abdelkefi A, Ben OT, Kammoun L et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. Thromb Haemost 2004; 92: 654-661.
-
(2004)
Thromb Haemost
, vol.92
, pp. 654-661
-
-
Abdelkefi, A.1
Ben, O.T.2
Kammoun, L.3
-
28
-
-
0029985941
-
Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin)
-
Monreal M, Alastrue A, Rull M et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-253.
-
(1996)
Thromb Haemost
, vol.75
, pp. 251-253
-
-
Monreal, M.1
Alastrue, A.2
Rull, M.3
-
29
-
-
12244279009
-
Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: A pilot randomized trial
-
Mismetti P, Mille D, Laporte S et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: A pilot randomized trial. Haematologica 2003; 88: 67-73.
-
(2003)
Haematologica
, vol.88
, pp. 67-73
-
-
Mismetti, P.1
Mille, D.2
Laporte, S.3
-
30
-
-
23044450305
-
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients
-
Verso M, Agnelli G, Bertoglio S et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4057-4062
-
-
Verso, M.1
Agnelli, G.2
Bertoglio, S.3
-
31
-
-
31544483971
-
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial
-
Karthaus M, Kretzschmar A, Kroning H et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006; 17: 289-296.
-
(2006)
Ann Oncol
, vol.17
, pp. 289-296
-
-
Karthaus, M.1
Kretzschmar, A.2
Kroning, H.3
-
32
-
-
69849113750
-
Short-term acenocumarine (A) or dalteparine (D) for the prevention of central venous catheter-related thrombosis (CVCrT) in cancer patients. A randomized controlled study based on serial venographies
-
Abstr 8549
-
DeCicco M, Matovic M, Pacenzia R et al. Short-term acenocumarine (A) or dalteparine (D) for the prevention of central venous catheter-related thrombosis (CVCrT) in cancer patients. A randomized controlled study based on serial venographies. J Clin Oncol 2006; 18S (Suppl): (Abstr 8549).
-
(2006)
J Clin Oncol
, vol.18 S
, Issue.SUPPL.
-
-
DeCicco, M.1
Matovic, M.2
Pacenzia, R.3
-
33
-
-
34548058576
-
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: A randomized, placebo-controlled study
-
Niers TM, Di NM, Klerk CP et al. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: A randomized, placebo-controlled study. J Thromb Haemost 2007; 5: 1878-1882.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1878-1882
-
-
Niers1
TM, D.N.2
Klerk, C.P.3
-
34
-
-
0036244604
-
Prophylaxis with urokinase in pediatric oncology patients with central venous catheters
-
Kalmanti M, Germanakis J, Stiakaki E et al. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters. Pediatr Hematol Oncol 2002; 19: 173-179.
-
(2002)
Pediatr Hematol Oncol
, vol.19
, pp. 173-179
-
-
Kalmanti, M.1
Germanakis, J.2
Stiakaki, E.3
-
35
-
-
0035448027
-
A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients
-
Biffi R, De Braud F, Orsi F et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 2001; 92: 1204-1212.
-
(2001)
Cancer
, vol.92
, pp. 1204-1212
-
-
Biffi, R.1
De Braud, F.2
Orsi, F.3
-
36
-
-
16644403169
-
A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports
-
Carlo JT, Lamont JP, McCarty TM et al. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 2004; 188: 722-727.
-
(2004)
Am J Surg
, vol.188
, pp. 722-727
-
-
Carlo, J.T.1
Lamont, J.P.2
McCarty, T.M.3
-
37
-
-
0031105419
-
A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy
-
Nightingale CE, Norman A, Cunningham D et al. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 1997; 33: 398-403.
-
(1997)
Eur J Cancer
, vol.33
, pp. 398-403
-
-
Nightingale, C.E.1
Norman, A.2
Cunningham, D.3
-
38
-
-
0034865573
-
Catheter-related upper extremity deep venous thrombosis in cancer patients: A prospective study based on Doppler US
-
Luciani A, Clement O, Halimi P et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: A prospective study based on Doppler US. Radiology 2001; 220: 655-660.
-
(2001)
Radiology
, vol.220
, pp. 655-660
-
-
Luciani, A.1
Clement, O.2
Halimi, P.3
-
39
-
-
17044410169
-
Thrombose symptomatique sur cathe' ter veineux central de longue durée en oncologie: Un score de risque prédictif?
-
Morazin F, Kriegel I, Asselain B, Falcou MC. Thrombose symptomatique sur cathe' ter veineux central de longue durée en oncologie: Un score de risque prédictif? Rev Med Intern 2005; 26: 273-279.
-
(2005)
Rev Med Intern
, vol.26
, pp. 273-279
-
-
Morazin, F.1
Kriegel, I.2
Asselain, B.3
Falcou, M.C.4
-
40
-
-
33645453557
-
Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer
-
Lee AY, Levine MN, Butler G et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-1408.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1404-1408
-
-
Lee, A.Y.1
Levine, M.N.2
Butler, G.3
-
41
-
-
0028834131
-
Complications of indwelling venous access devices in cancer patients
-
Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995; 13: 233-238.
-
(1995)
J Clin Oncol
, vol.13
, pp. 233-238
-
-
Eastridge, B.J.1
Lefor, A.T.2
-
42
-
-
0029986309
-
Hickman catheters: Left-sided insertion, male gender, and obesity are associated with an increased risk of complications
-
Craft PS, May J, Dorigo A et al. Hickman catheters: Left-sided insertion, male gender, and obesity are associated with an increased risk of complications. Aust N Z J Med 1996; 26: 33-39.
-
(1996)
Aust N Z J Med
, vol.26
, pp. 33-39
-
-
Craft, P.S.1
May, J.2
Dorigo, A.3
-
43
-
-
1642565440
-
To clot or not to clot? That is the question in central venous catheters
-
Cadman A, Lawrance JA, Fitzsimmons L et al. To clot or not to clot? That is the question in central venous catheters. Clin Radiol 2004; 59: 349-355.
-
(2004)
Clin Radiol
, vol.59
, pp. 349-355
-
-
Cadman, A.1
Lawrance, J.A.2
Fitzsimmons, L.3
-
44
-
-
21044452302
-
Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports
-
Caers J, Fontaine C, Vinh-Hung V et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 2005; 13: 325-331.
-
(2005)
Support Care Cancer
, vol.13
, pp. 325-331
-
-
Caers, J.1
Fontaine, C.2
Vinh-Hung, V.3
-
45
-
-
0032821861
-
Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity
-
Savage KJ, Wells PS, Schulz V et al. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 1999; 82: 1008-1010.
-
(1999)
Thromb Haemost
, vol.82
, pp. 1008-1010
-
-
Savage, K.J.1
Wells, P.S.2
Schulz, V.3
-
46
-
-
0027324812
-
Central venous catheter associated thrombosis of major veins: Thrombolytic treatment with recombinant tissue plasminogen activator
-
Rodenhuis S, van't Hek LG, Vlasveld LT et al. Central venous catheter associated thrombosis of major veins: Thrombolytic treatment with recombinant tissue plasminogen activator. Thorax 1993; 48: 558-559.
-
(1993)
Thorax
, vol.48
, pp. 558-559
-
-
Rodenhuis, S.1
van't Hek, L.G.2
Vlasveld, L.T.3
-
47
-
-
0032952343
-
Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue
-
Schindler J, Bona RD, Chen HH et al. Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue. Clin Appl Thromb Hemost 1999; 5: 25-29.
-
(1999)
Clin Appl Thromb Hemost
, vol.5
, pp. 25-29
-
-
Schindler, J.1
Bona, R.D.2
Chen, H.H.3
-
48
-
-
0029881245
-
Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusion implantables. A propos d'une se' rie consécutive de 57 thromboses et de 32 fibrinolyses.
-
Pucheu A, Dierhas M, Leduc B et al. Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusion implantables. A propos d'une se' rie consécutive de 57 thromboses et de 32 fibrinolyses. Bull Cancer 1996; 83: 293-299.
-
(1996)
Bull Cancer
, vol.83
, pp. 293-299
-
-
Pucheu, A.1
Dierhas, M.2
Leduc, B.3
-
49
-
-
0034518703
-
The treatment and outcome of cancer patients with thromboses on central venous catheters
-
Frank DA, Meuse J, Hirsch D et al. The treatment and outcome of cancer patients with thromboses on central venous catheters. J Thromb Thrombolysis 2000; 10: 271-275.
-
(2000)
J Thromb Thrombolysis
, vol.10
, pp. 271-275
-
-
Frank, D.A.1
Meuse, J.2
Hirsch, D.3
-
50
-
-
55549118564
-
Long-term use of daily subcutaneous low-molecular-weight heparin in cancer patients with venous thromboembolism: Why hesitate any longer?
-
Debourdeau P, Elalamy I, de Raignac A et al. Long-term use of daily subcutaneous low-molecular-weight heparin in cancer patients with venous thromboembolism: Why hesitate any longer? Support Care Cancer 2008; 16: 1333-1341.
-
(2008)
Support Care Cancer
, vol.16
, pp. 1333-1341
-
-
Debourdeau, P.1
Elalamy, I.2
de Raignac, A.3
|